Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome: The MARCADOR Study

Author： Martinez-Martin Francisco J.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.3, 2011-03, pp. : 201-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients

By Fogari Roberto   Preti Paola   Zoppi Annalisa   Lazzari Pierangelo   Corradi Luca   Fogari Elena   Ciccarelli Leonardina   Derosa Giuseppe  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 10, 2006-10 ,pp. : 817-822

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic Effects of Manidipine

By Cavalieri Luca   Cremonesi Giovanni  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 163-176

Adis International

Access to resources Recommend Favorite

Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

By Derosa G   D'Angelo A   Ragonesi PD   Ciccarelli L   Piccinni MN   Pricolo F   Salvadeo S   Montagna L   Gravina A   Ferrari I   Galli S   Paniga S   Cicero AFG  

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 545-555

Field House Publishing

Access to resources Recommend Favorite

Effects of canrenone in patients with metabolic syndrome

By Derosa Giuseppe   Bonaventura Aldo   Bianchi Lucio   Romano Davide   D'Angelo Angela   Fogari Elena   Maffioli Pamela  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2161-2169

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite